IL-6, TNF-α, MCP-1, and IL-1β mRNA levels were significantly raised in the CKD group (4.6-fold, 3.9-fold, 6.0-fold, and 3.4-fold, resp). This evidence concerns the gene CCL2 and chronic kidney disease.